{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:49:08Z","timestamp":1790833748602,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004358","name":"Samsung","doi-asserted-by":"publisher","award":["SRFC-MA1902-09"],"award-info":[{"award-number":["SRFC-MA1902-09"]}],"id":[{"id":"10.13039\/100004358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biomaterials.2021.121058","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T02:34:56Z","timestamp":1628130896000},"page":"121058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Repurposing macitentan with nanoparticle modulates tumor microenvironment to potentiate immune checkpoint blockade"],"prefix":"10.1016","volume":"276","author":[{"given":"Soyoung","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-2254","authenticated-orcid":false,"given":"Chan Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0133-7452","authenticated-orcid":false,"given":"Hyewon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Min","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5043-9455","authenticated-orcid":false,"given":"Jae Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biomaterials.2021.121058_bib1","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: harnessing the immune system to battle cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121058_bib2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00262-016-1910-x","article-title":"Immunotherapy, Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma","volume":"65","author":"Alva","year":"2016","journal-title":"Canc. Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121058_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121058_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41591-019-0564-6","article-title":"Clinical lessons learned from the first leg of the CAR T cell journey","volume":"25","author":"Majzner","year":"2019","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.biomaterials.2021.121058_bib5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121058_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.biomaterials.2021.121058_bib7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2021.121058_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ctrv.2017.12.008","article-title":"Checkpoint inhibitors in breast cancer \u2013 current status","volume":"63","author":"Polk","year":"2018","journal-title":"Canc. Treat Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-017-0013-7","article-title":"Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy","volume":"7","author":"Cheng","year":"2018","journal-title":"Oncogenesis"},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121058_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2021.121058_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.trecan.2019.09.009","article-title":"Fibroblasts fuel immune escape in the tumor microenvironment","volume":"5","author":"De Jaeghere","year":"2019","journal-title":"Trend. Cancer"},{"issue":"7637","key":"10.1016\/j.biomaterials.2021.121058_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121058_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies, Nature reviews","volume":"18","author":"Galon","year":"2019","journal-title":"Drug Discover."},{"key":"10.1016\/j.biomaterials.2021.121058_bib14","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121058_bib15","first-page":"174","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts, Nature reviews","volume":"20","author":"Sahai","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121058_bib16","first-page":"282","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer, Nature reviews","volume":"16","author":"Kobayashi","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121058_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Canc."},{"issue":"6230","key":"10.1016\/j.biomaterials.2021.121058_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121058_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.biomaterials.2021.121058_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41416-019-0705-1","article-title":"The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome","volume":"122","author":"D'Arcangelo","year":"2020","journal-title":"Br. J. Canc."},{"issue":"7718","key":"10.1016\/j.biomaterials.2021.121058_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121058_bib24","first-page":"209","article-title":"The importance of exosomal PDL1 in tumour immune evasion, Nature reviews","volume":"20","author":"Daassi","year":"2020","journal-title":"Immunology"},{"issue":"24","key":"10.1016\/j.biomaterials.2021.121058_bib25","first-page":"1901779","article-title":"Extracellular vesicles in cancer immune microenvironment and cancer immunotherapy","volume":"6","author":"Xie","year":"2019","journal-title":"Adv. Sci. (Weinheim Baden Wurttemberg, Germaby)"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121058_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/onc.2013.560","article-title":"Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes","volume":"34","author":"Webber","year":"2015","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121058_bib27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1159\/000493218","article-title":"Exosomal miR-27a derived from gastric cancer cells regulates the transformation of fibroblasts into cancer-associated fibroblasts, cellular physiology and biochemistry","volume":"49","author":"Wang","year":"2018","journal-title":"Int. J. Expertment. Cell. Physiol. Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41467-017-02583-0","article-title":"Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer","volume":"9","author":"Fang","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121058_bib29","first-page":"277","article-title":"Cancer-associated fibroblasts: perspectives in cancer therapy","volume":"2","author":"Prakash","year":"2016","journal-title":"Trand. Canc."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121058_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc990","article-title":"The endothelin axis: emerging role in cancer","volume":"3","author":"Nelson","year":"2003","journal-title":"Nat. Rev. Canc."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121058_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030824","article-title":"Endothelin receptor antagonists: status quo and future perspectives for targeted therapy","volume":"9","author":"Enevoldsen","year":"2020","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121058_bib32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc3546","article-title":"Endothelin 1 in cancer: biological implications and therapeutic opportunities","volume":"13","author":"Rosan\u00f2","year":"2013","journal-title":"Nat. Rev. Canc."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/07853890410018925","article-title":"Role of endothelin in fibrosis and anti-fibrotic potential of bosentan","volume":"37","author":"Clozel","year":"2005","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm1699","article-title":"Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy","volume":"14","author":"Buckanovich","year":"2008","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib35","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41467-019-09387-4","article-title":"Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A","volume":"10","author":"Im","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121058_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","article-title":"Endothelins in cardiovascular biology and therapeutics","volume":"16","author":"Dhaun","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2021.121058_bib37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jconrel.2015.10.006","article-title":"Control of polymeric nanoparticle size to improve therapeutic delivery","volume":"219","author":"Hickey","year":"2015","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121058_bib38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121058_bib39","first-page":"188356","article-title":"Fibrosis and cancer: a strained relationship, Biochimica et biophysica acta","volume":"1873","author":"Piersma","year":"2020","journal-title":"Rev. Canc."},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121058_bib40","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Canc."},{"issue":"11","key":"10.1016\/j.biomaterials.2021.121058_bib41","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.apsb.2020.04.005","article-title":"Natural products remodel cancer-associated fibroblasts in desmoplastic tumors","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.biomaterials.2021.121058_bib42","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1073\/pnas.1815515116","article-title":"Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer","volume":"116","author":"Chen","year":"2019","journal-title":"Proceed. Nation. Acad. Sci. USA"},{"issue":"38","key":"10.1016\/j.biomaterials.2021.121058_bib43","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.1213353109","article-title":"Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors","volume":"109","author":"Stylianopoulos","year":"2012","journal-title":"Proceed. Nation. Acad. Sci. USA"},{"issue":"7693","key":"10.1016\/j.biomaterials.2021.121058_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"7693","key":"10.1016\/j.biomaterials.2021.121058_bib45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13075-015-0754-7","article-title":"Macitentan inhibits the transforming growth factor-\u03b2 profibrotic action, blocking the signaling mediated by the ETR\/T\u03b2RI complex in systemic sclerosis dermal fibroblasts","volume":"17","author":"Cipriani","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biomaterials.2021.121058_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2018.00018","article-title":"Exosome-based cell-cell communication in the tumor microenvironment","volume":"6","author":"Maia","year":"2018","journal-title":"Frontiers in cell and developmental biology"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib48","doi-asserted-by":"crossref","first-page":"1599680","DOI":"10.1080\/20013078.2019.1599680","article-title":"Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b","volume":"8","author":"Vu","year":"2019","journal-title":"J. Extracell. Vesicles"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121058_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"S","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib50","doi-asserted-by":"crossref","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","volume":"9","author":"Catalano","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121058_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ncb2000","article-title":"Rab27a and Rab27b control different steps of the exosome secretion pathway","volume":"12","author":"Ostrowski","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121058_bib52","first-page":"1491","article-title":"Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model, Cancer Immunology","volume":"65","author":"Dyck","year":"2016","journal-title":"Immunotherapy"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221004142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221004142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:05:35Z","timestamp":1758906335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961221004142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":52,"alternative-id":["S0142961221004142"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121058","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing macitentan with nanoparticle modulates tumor microenvironment to potentiate immune checkpoint blockade","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121058"}}